Partner in charge

SH&P Advises IBA Proton Therapy on ProteusONE Project in Egypt

Soliman, Hashish & Partners (SH&P) advised IBA Proton Therapy on the Egyptian legal aspects of the ProteusONE project in Egypt at Children’s Cancer Hospital Egypt 57357 (CCHE 57357).

Frédéric Soliman, Managing Partner at SH&P, led the firm’s involvement with support from the SH&P team.

Project at a Glance

Client: IBA Proton Therapy

Project: Proteus®ONE Proton Therapy System

Location: Children’s Cancer Hospital Egypt 57357

SH&P Role: Adviser on the Egyptian legal aspects of the project

Lead Partner: Frédéric Soliman

Current Milestone: Installation and formal acceptance completed

ProteusONE Project in Egypt Reaches Installation and Formal Acceptance

The ProteusONE project in Egypt has reached the installation and formal acceptance milestone. The Centre is now preparing to welcome its first patients. As a result, the Centre is preparing to welcome its first patients.

According to the project announcement, the project developed over several years. It involved professionals across engineering, healthcare, project management and legal disciplines.

Throughout this period, the teams worked together to reach the current stage. In addition, the announcement linked this milestone to the planned introduction of proton therapy services for children in Egypt and the region.

SH&P’s Legal Role

SH&P advised IBA Proton Therapy throughout the Egyptian legal aspects of the project. During its implementation, the firm provided legal guidance in Egypt.

IBA Proton Therapy acknowledged the firm’s involvement in the project announcement:

“A special thank you to Frédéric Soliman and his team at Soliman, Hashish & Partners, whose expertise and guidance played a key role in bringing this project to a successful conclusion.”

SH&P appreciates the trust placed in the firm by IBA Proton Therapy.

SH&P congratulates IBA Proton Therapy, Children’s Cancer Hospital Egypt 57357 and the project teams involved in reaching this milestone.